{"url_path":"/sec/ew/8-k/2026-05-08/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1099800/0001099800-26-000028-index.html","accession_number":"0001099800-26-000028","cik":"0001099800","ticker":"EW","issuer_name":"Edwards Lifesciences Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1099800/0001099800-26-000028-index.html","primary_entity_key":"0001099800","primary_entity_name":"Edwards Lifesciences Corp"},"word_count":185,"has_tables":true,"body_markdown":"Item 5.07 Submission of Matters to a Vote of Security Holders\n\nThe final results of voting for each matter submitted to a vote of stockholders at the Annual Meeting, which was held on May 7, 2026, are as follows:\n\nProposal 1: All the nominees for director listed in Proposal 1 were elected to serve until the Company’s next annual meeting of stockholders and until their respective successors are duly elected and qualified as set forth below:\n\nNomineeForAgainstAbstainBroker Non-Votes\n\nLeslie C. Davis461,819,76513,184,241881,73327,211,476\n\nDavid T. Feinberg, MD473,746,1441,812,520327,07627,211,476\n\nKieran T. Gallahue457,045,40318,518,195322,14227,211,476\n\nLeslie S. Heisz454,955,19520,567,869362,67627,211,476\n\nPaul A. LaViolette428,701,64645,445,2761,738,81727,211,476\n\nSteven R. Loranger446,216,43428,909,945759,36127,211,476\n\nRamona Sequeira474,260,5521,295,682329,50627,211,476\n\nNicholas J. Valeriani441,224,09534,327,820333,82527,211,476\n\nBernard J. Zovighian459,179,72716,257,009449,00427,211,476\n\nProposal 2: The advisory proposal regarding the Company’s named executive officer compensation was approved as set forth below:\n\nForAgainstAbstainBroker Non-Votes\n\n424,961,63950,924,101027,211,476\n\nProposal 3: Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved as set forth below:\n\nForAgainstAbstainBroker Non-Votes\n\n446,283,14256,814,075027,211,476\n\n2\n\nProposal 4: The approval of the Company’s Amended and Restated Long-Term Stock Incentive Compensation Program was approved as set forth below:\n\nForAgainstAbstainBroker Non-Votes\n\n456,675,20119,210,539027,211,476"}